ClinicalTrials.Veeva

Menu

Automated Oxygen Titration with O2matic Home Oxygen Therapy (O2matic HOT) Phase 1 (O2matic-HOT1)

H

Hvidovre University Hospital

Status

Terminated

Conditions

Chronic Hypoxemic Respiratory Failure
COPD

Treatments

Device: O2matic HOT
Device: Oxygen concentrator

Study type

Interventional

Funder types

Other

Identifiers

NCT04606290
O2matic-HOT1

Details and patient eligibility

About

O2matic HOT is a further development of O2matic and is intended for home oxygen use with patients in need of long-term oxygen treatment (LTOT). O2matic HOT is a closed-loop system which on basis of signals from pulse oximetry titrates the oxygen flow to the patient. In this crossover trial patients are admitted for 24 hours twice. Once with usual fixed dose oxygen and once with oxygen titration by O2matic HOT.

Full description

The purpose of this study is to examine if automated oxygen control based on pulse oximetry to patients with domiciliary long-term oxygen treatment (LTOT) is better than manually controlled oxygen treatment in keeping SpO2 within intended target interval. In manually controlled oxygen treatment flow is usually kept constant for months between visits from specialist nurse, whereas in automated control the patient can titrate oxygen flow several times a day based on pulse oximetry in a closed-loop system.

Enrollment

10 patients

Sex

All

Ages

40+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Verified COPD with FEV1/FVC < 0.70
  • Need of LTOT (PaO2 <= 7.3 kPa or SpO2 < 88 % on ambient air)
  • Cognitively able to participate
  • Willing to provide informed consent

Exclusion criteria

  • Moderate or severe exacerbation in COPD within 4 weeks from study start
  • Major comorbidities (cancer, uncontrolled chronic disease)
  • Asthma or other disease with need of higher SpO2
  • Pregnancy
  • Fall in pH below 7.35 or increase in PaCO2 > 1 kPa on 5 liters of oxygen
  • Active smoking
  • LTOT use less than 1 hours/day

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Crossover Assignment

Masking

None (Open label)

10 participants in 2 patient groups

Manual
Active Comparator group
Description:
Fixed dose oxygen
Treatment:
Device: Oxygen concentrator
O2matic
Experimental group
Description:
Automated oxygen titration
Treatment:
Device: O2matic HOT

Trial contacts and locations

2

Loading...

Central trial contact

Uffe Boedtker, PhD; Ejvind F Hansen, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems